IP Library Granted Patent US 8,114,887
Granted Patent B2
US 8,114,887 · App. 11/663,388 · Granted Feb 14, 2012

Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,887
App. No.
11/663,388
Granted
Feb 14, 2012
Kind
B2
Abstract

The present invention is directed to spiropiperidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

Claims (584)

1. A compound of formula (I):

or its tautomer (I′)

wherein:

X is N;

X′ is NH;

Z is O;

R 1 is selected from the group consisting of

(3) —C 0-6 alkyl-C 6-10 aryl,

(5) —C 0-6 alkyl-C 3-12 carbocyclic,

said R 1 carbocyclic moiety is substituted with one or more

(a) —OR 4 ,

(b) ═O,

(c) halogen,

(d) cyano,

(e) —C(═O)—NR 4 R 4′ ,

(f) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen,

(II) —OH, and

(III) —C 6-10 aryl,

(g) —NR 4 —SO 2 —R 4′ ,

(h) —SO 2 —R 4 ,

(i) —NR 4 —C(═O)—R 4′ ,

(j) —C(═O)—OR 4 ,

(k) —NR 4 R 4′ ,

(l) —C(═O)—R 4 , and

(m) —SO 2 —NR 4 R 4′ ,

and said R 1 aryl is optionally substituted with one or more

(a) halogen,

(b) —C 1-6 alkyl,

(c) —C 2-6 alkenyl,

(d) —C 2-6 alkynyl,

(e) —C 0-3 alkyl-C 6-10 aryl,

(f) cyano,

(g) —O—C 0-3 alkyl-C 6-10 aryl,

(h) —O—R 4 ,

(i) —C(═O)—NR 4 R 4′ ,

(j) —NR 4 R 4′ ,

(k) -Q 2 -R 7 , and

(l) —C 0-3 alkyl-C 5-12 heteroaryl,

Q 2 is selected from the group consisting of

(a) —C(═O)—,

(b) —C(═O)—O—,

(c) —C(═O)—NR 8 —,

(d) —NR 8 —C(═O)—,

(e) —S(═O) n —,

(f) —Si(R 8 R 9 )—,

(g) —S(═O) 2 —R 8 —,

(h) —R 8 —S(═O) 2 —,

(i) —O—C(═O)—,

(j) —NR 8 —C(═O)—O—,

(k) —SO 2 —NR 4 —,

(l) —NR 4 SO 2 —,

(m) —NR 4 —

wherein n is 0, 1 or 2;

R 2 is selected from the group consisting of

(4) —C 0-6 alkyl-C 6-10 aryl,

and said R 2 aryl is optionally substituted with one or more

(a) —OR 10 ,

(b) halogen,

(c) -cyano,

(d) —NO 2 ,

(e) -Q 4 -C 1-6 alkyl,

(f) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen, and

(II) cyano,

(g) —C 0-3 alkyl-C 6-10 aryl, wherein said aryl is optionally substituted with one or more

(I) halogen,

(II) —C 1-6 alkyl,

(III) —C 2-6 alkenyl,

(IV) —C 2-6 alkynyl,

(V) —O—C 1-6 alkyl,

(VI) —SO 2 —C 1-6 alkyl,

(VII) cyano,

(VIII) —C 3-8 cycloalkyl,

(IX) —NO 2 ,

(X) —SO 2 —NR 4 R 4′

(h) —SO 2 —C 1-6 alkyl,

(i) —SO 2 —NR 4 R 4′ ,

(j) —NR 4 R 4′ ,

(k) —C 3-8 cycloalkyl,

(l) —C 2-6 alkenyl,

(m) —NHC(═O)—C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) —NR 4 R 4′

(II) OH

(III) —SO 2 R 4 , and

(IV) —NHSO 2 R 4 ,

(n) —NHC(═O)—C 0-3 alkyl-C 6-10 aryl, wherein said aryl is optionally substituted with one or more

(I) NR 4 R 4′ ,

(II) OH,

(III) —SO 2 R 4 , and

(IV) —NHSO 2 R 4 ,

(o) —C 0-3 alkyl-C 5-12 heteroaryl, wherein said heteroaryl is optionally substituted with one or more

(I) halogen,

(II) —C 1-6 alkyl, and

(III) ═O,

(p) —S(═O) m —C 0-6 alkyl-C 6-10 aryl,

(q) —CO 2 —R 4 ,

(r) —C(═O)—NR 4 R 4′ ,

(s) —C 0-6 alkyl—NR 4 SO 2 —R 4 ,

(t) —O—C 2-6 alkenyl,

and m is 0, 1 or 2;

and Q 4 is selected from the same group as Q 2 ;

R 3 is selected from the group consisting of

(2) —C 0-3 alkyl-C 6-10 aryl,

and said R 3 aryl is optionally substituted with one or more

(a) —OR 12 ,

(b) —NR 4 R 4′ ,

(c) halogen,

(d) cyano,

(f) —NO 2 ,

(g) -Q 6 -R 4 , and

(h) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen,

(II) cyano,

(III) —C 1-6 alkyl,

(IV) —O—C 1-6 alkyl,

(V) —C 3-8 cycloalkyl,

(VI) —C(═O)—C 1-6 alkyl,

(i) —C 2-6 alkenyl,

(j) —C 2-6 alkynyl,

(k) —C 0-3 alkyl-C 5-12 heteroaryl,

(l) —O—C 2-6 alkenyl,

(m) —C 0-3 alkyl-C 6-10 aryl, wherein said aryl moiety is optionally substituted with one or more

(I) —C 1-6 alkyl,

(II) —C 2-6 alkenyl,

(III) —C 2-6 alkynyl,

(IV) halogen,

(V) cyano,

(VI) —C 3-8 cycloalkyl, and

(VII) NO 2 ,

and R 12 is selected from the group consisting of

(I) hydrogen,

(II) —C 1-6 alkyl,

(III) —C 2-6 alkenyl,

(IV) —C 2-6 alkynyl,

(V) —C 3-8 cycloalkyl, and

(VI) —C 0-3 alkyl-C 6-10 aryl,

and said R 12 alkyl, alkenyl and alkynyl moiety is optionally substituted with one or more

(A) halogen,

(B) hydroxyl,

(C) cyano,

(D) —O—C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more halogen,

(E) —NR 4 R 4′ ,

(F) —NR 4 —S(═O) 2 —R 4′ ,

(G) —NR 4 —C(═O)—R 4′ ,

(H) —NR 4 —C(═O)—OR 4′ ,

(I) —S(═O) 2 —NR 4 —,

and said R 10 cycloalkyl moiety is optionally substituted with one or more

(A) halogen,

(B) hydroxyl,

(C) -cyano,

(D) —O—Cl 1-6 alkyl, and

(E) —C 1-6 alkyl, wherein said alkyl is optionally substituted one or more halogen;

and said R 12 aryl moiety is optionally substituted with one or more

(A) halogen,

(B) cyano,

(C) —O—C 1-6 alkyl, and

(D) —C 1-6 alkyl, wherein said alkyl is optionally substituted one or more halogen;

Q 6 is selected from the same group as Q 2 ;

R 4 and R 4′ are selected from the group consisting of

(1) hydrogen,

(2) —C 1-8 alkyl, wherein said alkyl is optionally substituted with

(a) halogen,

(b) —C 3-8 cycloalkyl

(c) —CO 2 C 1-6 alkyl

(d) —OC 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen, or

(II) cyano,

(3) —C 2-8 alkenyl, and

(4) —C 0-3 alkyl-C 6-10 aryl;

R 5 is selected from the group consisting of

(1) hydrogen,

(2) —C 1-6 alkyl,

(3) halogen, and

(4) —CO 2 —R 4 ,

R 6 , R 7 , R 8 , R 9 , R 10 and R 11 are independently selected from the group consisting of:

(1) hydrogen,

(2) —C 1-6 alkyl,

(3) —C 3-8 cycloalkyl,

(4) —C 0-3 alkyl-C 6-10 aryl,

wherein said alkyl is optionally substituted with one or more

(A) halogen,

(B) hydroxyl,

(C) cyano,

(D) —O—C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

halogen,

and said cycloalkyl and aryl are optionally substituted with one or more

(A) halogen,

(B) hydroxyl,

(C) cyano,

(D) —O—C 1-6 alkyl, and

(E) —C 1-6 alkyl, wherein said alkyl is optionally substituted one or more halogen;

provided that when X is N; Z is O; and R 2 is unsubstituted phenyl, then R 3 is not unsubstituted benzyl;

and pharmaceutically acceptable salts thereof, and individual enantiomers and diastereomers thereof.

2. The compound of claim 1 wherein R 1 is —C 0-3 alkyl-C 3-12 carbocyclic, wherein said alkyl or carbocyclic is substituted as in claim 1 .

3. The compound of claim 1 wherein R 1 is —C 0-3 alkyl-C 6-10 aryl, and said aryl moiety is optionally substituted with one or more

(a) halogen, or

(b) —C 1-6 alkyl.

4. The compound of claim 1 wherein R 2 is: —C 0-3 alkyl-C 6-10 aryl, wherein said aryl moiety is optionally substituted as in claim 1 .

5. The compound of claim 4 , wherein R 2 is phenyl or benzyl, and said phenyl or benzyl are optionally substituted as in claim 1 .

6. The compound of claim 1 which is a compound of formula (II)

or its tautomer (II′)

and pharmaceutically acceptable salts thereof, and individual enantiomers and diasteromers thereof, wherein X, X′, Z, R 1 and R 3 are as defined in claim 1 , and R 15 is selected from the group consisting of

(a) —OR 10 ,

(b) halogen,

(c) -cyano,

(d) -Q 4 -C 1-6 alkyl,

(e) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen, and

(II) cyano,

(f) —C 0-3 -alkyl-C 6-10 aryl, wherein said aryl is optionally substituted with one or more

(I) halogen,

(II) —C 1-6 alkyl,

(V) —O—C 1-6 alkyl,

(VI) —SO 2 —C 1-6 alkyl,

(VII) cyano,

(VIII) —C 3-8 cycloalkyl,

(X) —SO 2 —NR 4 R 4′

(g) —SO 2 —C 1-6 alkyl,

(h) —SO 2 —NR 4 R 4′ ,

(i) —C 3-8 cycloalkyl,

(j) —NHC(═O)—C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) —NR 4 R 4′

(II) OH

(III) —SO 2 R 4 , and

(IV) —NHSO 2 R 4 ,

(k) —C 0-3 alkyl-C 5-12 heteroaryl, wherein said heteroaryl is optionally substituted with one or more

(I) halogen,

(II) —C 1-6 alkyl, and

(III) ═O,

(l) —S(═O) m —C 0-6 alkyl-C 6-10 aryl,

(m) —CO 2 —R 4 ,

(n) —C(═O)—NR 4 R 4′ ,

(o) —C 0-6 alkyl-NR 4 SO 2 —R 4 .

7. The compound of claim 6 wherein R 3 is selected from the group consisting of

(1) —C 0-3 alkyl-C 6-10 aryl,

and said aryl is optionally substituted with one or more

(a) —OR 12 ,

(b) —NR 4 R 4′ ,

(c) halogen,

(d) cyano,

(e) —NO 2 ,

(f) -Q 6 -R 4 , and

(g) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen,

(II) cyano,

(III) —C 1-6 alkyl,

(IV) —O—C 1-6 alkyl,

(V) —C 3-8 cycloalkyl,

(VI) —C(═O)—C 1-6 alkyl,

(h) —C 2-6 alkenyl,

(i) —C 2-6 alkynyl,

(j) —C 0-3 alkyl-C 5-12 heteroaryl,

(k) —C 0-3 alkyl-C 6-10 aryl, and said aryl moiety is optionally substituted with one or more

(I) —C 1-6 alkyl,

(II) —C 2-6 alkenyl,

(III) —C 2-6 alkynyl,

(IV) halogen,

(V) cyano,

(VI) —C 3-8 cycloalkyl, and

(VII) NO 2 .

8. The compound of claim 7 wherein R 3 is benzyl, which is optionally substituted with one or more

(a) —OR 12 ,

(b) NR 4 R 4′ ,

(c) halogen,

(d) cyano,

(f) —NO 2 ,

(g) -Q 6 -R 4 , and

(h) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen,

(II) cyano,

(III) —C 1-6 alkyl,

(IV) —O—C 1-6 alkyl,

(V) —C 3-8 cycloalkyl,

(VI) —C(═O) —C 1-6 alkyl,

(i) —C 2-6 alkenyl,

(j) —C 2-6 alkynyl,

(k) —C 0-3 alkyl-C 5-12 heteroaryl,

(l) —C 0-3 alkyl-C 6-10 aryl, and said aryl moiety is optionally substituted with one or more

(I) —C 1-6 alkyl,

(II) —C 2-6 alkenyl,

(III) —C 2-6 alkynyl,

(IV) halogen,

(V) cyano,

(VI) —C 3-8 cycloalkyl, and

(VII) NO 2 .

9. The compound of claim 1 which is a compound of formula (III)

or its tautomer (III')

and pharmaceutically acceptable salts thereof, and individual enantiomers and diastereomers thereof, wherein X, X′, Z, R 1 , and R 2 are as defined in claim 1 , and R 16 is selected from the group consisting of

(a) —OR 12 ,

(b) NR 4 R 4′ ,

(c) halogen,

(d) cyano,

(f) —NO 2 ,

(g) -Q 6 -R 4 , and

(h) —C 1-6 alkyl, wherein said alkyl is optionally substituted with one or more

(I) halogen,

(II) cyano,

(III) —C 1-6 alkyl,

(IV) —O—C 1-6 alkyl,

(V) —C 3-8 cycloalkyl,

(VI) —C(═O)—C 1-6 alkyl,

(i) —C 2-6 alkenyl,

(j) —C 2-6 alkynyl,

(k) —C 0-3 alkyl-C 5-12 heteroaryl,

(l) —C 0-3 alkyl-C 6-10 aryl, wherein said aryl moiety is optionally substituted with one or more

(I) —C 1-6 alkyl,

(II) —C 2-6 alkenyl,

(III) —C 2-6 alkynyl,

(IV) halogen,

(V) cyano,

(VI) —C 3-8 cycloalkyl, and

(VII) NO 2 .

10. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

11. A compound which is selected from the group consisting of:

8-benzyl-4-(benzylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-methylbutyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(tert-butylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(isopropylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-pyridyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(butylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3,5-dimethylphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(1-methylbutylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-chlorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-methoxy-3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3,4-difluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-trifluoromethylphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(2-methylphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3,4-dichlorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-trifluoromethylphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-chlorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(2-chlorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(2,4-dichlorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-cyanophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(2-trifluoromethyl-4-methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(2-methyl-4-methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(1,3-benzodioxo-5-yl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-acetylaminophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3,5-difluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-((2-phenethyl)amino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-pentanoylaminophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(4-(4-dimethylamino)butanoylaminophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-{4-[8-benzyl-4-(cyclohexylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]phenyl}butanamide;

N-{4-[8-benzyl-4-(cyclohexylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]phenyl}-3-hydroxypropanamide;

ethyl N-[8-benzyl-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-4-yl]-beta-alaninate;

8-benzyl-4-(cyclohexylamino)-1-[3′-(methylsulfonyl)biphenyl-2-yl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(isopropylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-{4-[8-benzyl-4-(cyclohexylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]-2-chlorophenyl}acetamide;

8-(3-Bromobenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{3-[(1-methylprop-2-enyl)oxy]benzyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-methyl-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-ene;

1-(3-fluorophenyl)-4-(methylamino)-8-[(2′-methylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-1-(3-fluorophenyl)-4-(methylamino)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-(4-{[1-(3-fluorophenyl)-4-(methylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)acetamide;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-vinyl-1,1′-biphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(4-methylpyridin-3-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(2-trifluoromethoxybenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[2-(difluoromethoxy)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[2-(tert-butylthio)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[2-methylbenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[2-nitrobenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-(4-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)acetamide;

8-[4-cyanobenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-cyanobenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[2-propoxybenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-phenylpropyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-fluorobenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[2-cyanobenzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(2-thienylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1-phenylethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(2-benzyl-1H-indol-7-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(2-benzyl-2,3-dihydro-1H-indol-7-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1H-pyrrol-2-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1H-indol-2-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(3-aminopyridin-4-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(quinolin-6-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1,2,3,4-tetrahydroquinolin-6-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1H-indol-7-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(2-aminopyridin-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1H-indol-5-ylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-(2,3-dihydro-1H-indol-5-ylmethyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(2-aminobenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-(2,3-dihydro-1H-indol-7-ylmethyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-(2,3-dihydro-1H-inden-2-yl)-1-(3-fluorophenyl)-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-phenylcyclohexyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(1-phenyl-2,3-dihydro-1H-inden-2-yl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-phenylcyclohexyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(4-methoxyphenoxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{4-[(4-methoxybenzyl)oxy]benzyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(biphenyl-3-ylmethyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-methylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(3-chlorobenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-methylbenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(trifluoromethyl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-vinylbenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

methyl 3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}benzoate;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-hydroxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-methoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-(3-ethoxybenzyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(cyclopentyloxy)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(1,1,2,2-tetrafluoroethoxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-phenoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(4-tert-butylphenoxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(3,5-dichlorophenoxy)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(benzyloxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-nitrobenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl acetate;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(2-methyl-1H-imidazol-1-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(2-ethyl-1H-imidazol-1-yl)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

3′-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}biphenyl-2-carbonitrile;

4-(cyclohexylamino)-8-[(2′-ethylbiphenyl-3-yl)methyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[2′-(methoxymethyl)biphenyl-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[2′-(trifluoromethyl)biphenyl-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-vinylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-methoxybiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

(3′-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}biphenyl-2-yl)acetonitrile;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(2-fluoropyridin-3-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(3-methylpyridin-4-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(4′-methylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(3′-methylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-{[6-(2-ethylphenyl)pyridin-2-yl]methyl}-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[(2′-cyclopropylbiphenyl-3-yl)methyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(5-methyl-2-furyl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(2′-allylbiphenyl-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-({2′-[(trimethylsilyl)ethynyl]biphenyl-3-yl}methyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(2-methylpyridin-3-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(3,5-dimethylisoxazol-4-yl)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[(2′-ethynylbiphenyl-3-yl)methyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(2′-but-3-en-1-ylbiphenyl-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-isopropylbiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(3-methylpyridin-2-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(1-methyl-1H-imidazol-2-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(4-methylpyridin-3-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(1-methyl-1H-imidazol-5-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(1-methyl-1H-imidazol-4-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(4-methyl-1-oxidopyridin-3-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[(2′,4′-dimethoxy-6′-methylbiphenyl-3-yl)methyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[2′-(2-methylprop-2-en-1-yl)biphenyl-3-yl]methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(2′-methyl-5′-nitrobiphenyl-3-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[(5′-fluoro-2′-methylbiphenyl-3-yl)methyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(5′-chloro-2′-methylbiphenyl-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(5′-amino-2′-methylbiphenyl-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-hydroxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(3-tert-butoxybenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(allyloxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(but-3-enyloxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-(2,3-dihydro-1-benzofuran-7-ylmethyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(allyloxy)benzyl]-4-(cyclohexylamino)-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(prop-2-ynyloxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(cyclopropylmethoxy)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-propoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(3-sec-butoxybenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(2-methoxy-1-methylethoxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(pentyloxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-[3-(1-ethylpropoxy)benzyl]-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(trifluoromethoxy)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(1H-pyrrol-1-yl)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

methyl 3-(3′-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}biphenyl-2-yl)propanoate;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(2-furylmethyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-4-(isopropylamino)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(6-bromopyridin-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorphenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-{[6-(Benzylamino)pyridin-3-yl]methyl}-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

tert-Butyl 5-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}pyridin-2-ylcarbamate;

8-[(6-aminopyridin-3-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-ene;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[6-(isobutylamino)pyridin-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[6-(isopropylamino)pyridin-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-{[6-(butylamino)pyridin-3-yl]methyl}-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-({6-[(2-methoxyethyl)amino]pyridin-3-yl}methyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-({6-[(cyclopropylmethyl)amino]pyridin-3-yl}methyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-({6-[(3-phenylpropyl)amino]pyridin-3-yl}methyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[2-(methylamino)pyridin-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[2-(isopropylamino)pyridin-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-({2-[(2-methoxyethyl)amino]pyridin-3-yl}methyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[2-(isobutylamino)pyridin-3-yl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-({2-[(cyclopropylmethyl)amino]pyrid in-3-yl}methyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-({2-[(3-phenylpropyl)amino]pyridin-3-yl}methyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-{[2-(sec-butylamino)pyridin-3-yl]methyl}-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-({2-[(2,2-dimethylpropyl)amino]pyridin-3-yl}methyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-{[2-(ethylamino)pyridin-3-yl]methyl}-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-{[2-(cyclopropylamino)pyridin-3-yl]methyl}-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-({2-[(2,2-difluoroethyl)amino]pyridin-3-yl}methyl)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-8-{2-[(2,2-difluoroethyl)amino]benzyl}-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

tert-Butyl 2-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenoxy)propylcarbamate;

8-[3-(2-amino-1-methylethoxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-[4-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenoxy)butyl]methanesulfonamide;

tert-butyl 3-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenoxy)butylcarbamate;

8-[3-(3-amino-1-methylpropoxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

tert-butyl 2-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenoxy)butylcarbamate;

8-{3-[1-(aminomethyl)propoxy]benzyl}-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(2-aminoethoxy)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[3-(aminomethyl)benzyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-(3-aminobenzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

N-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)acetamide;

N-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)methane sulfonamide;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{3-[(2-methylpentyl)amino]benzyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[3-(isopropylamino)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[2-(isopropylamino)benzyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

4-[(2-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)amino]butanenitrile;

3-(3-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)-2-methylpropanenitrile;

4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(6-isopropoxypyridin-2-yl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

8-[(6-sec-butoxypyridin-2-yl)methyl]-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one;

1-(3-Fluorophenyl)-4-isobutylamino-8-(3-isopropoxy-benzyl)-1,3,8-triaza-spiro[4.5]dec-3-en-2-one;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(2-methyl-cyclohexylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(1,2-Dimethyl-propylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(2-Fluoro-cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cycloheptylamino-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(Bicyclo[2.2.1]hept-2-ylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclopentylamino-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-4-(tetrahydro-pyran-4-ylamino)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclobutylamino-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluoro-phenyl)-8-(3-isopropoxy-benzyl)-2-oxo-4-(2-pyridin-4-yl-ethylamino)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-(3-hydroxy-cyclohexylamino)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-(1-hydroxymethyl-2-methyl-propylamino)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(3-methyl-butylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(Cyclopropylmethyl-amino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(1-methanesulfonyl-pyrrolidin-3-ylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Benzylamino-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(1-Acetyl-pyrrolidin-3-ylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-4-(3-phenyl-propylamino)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-(3-hydroxy-cyclohexylamino)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(2-Dimethylcarbamoyl-ethylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-(2-Fluoro-ethylamino)-1-(3-fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-[(furan-2-ylmethyl)-amino]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-4-(2-thiophen-2-yl-ethylamino)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(2-methylsulfanyl-ethylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(2-morpholin-4-yl-ethylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-[2-(1H-imidazol-4-yl)-ethylamino]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-4-(1-hydroxymethyl-cyclopentylamino)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-4-(2-methanesulfonyl-ethylamino)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(3-Fluorophenyl)-8-(3-isopropoxy-benzyl)-2-oxo-4-phenylamino-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

2′-[4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3,8-triaza-spiro[4.5]dec-3-en-1-yl]-4′-fluoro-biphenyl-4-sulfonic acid dimethylamide;

4-Cyclohexylamino-1-(3′-methoxy-biphenyl-2-yl)-8-(2′-methyl-biphenyl-3-ylmethyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(4′-Cyano-biphenyl-2-yl)-4-cyclohexylamino-8-(2′-methyl-biphenyl-3-ylmethyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(2-Cyano-phenyl)-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(2-Bromo-5-fluorophenyl)-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1-(2-phenylsulfanyl-phenyl)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1-(3′-trifluoromethyl-biphenyl-2-yl)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(2-Benzyl-phenyl)-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(4′-Carboxy-biphenyl-2-yl)-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1-(4′-trifluoromethoxy-biphenyl-2-yl)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-[2-(1H-indol-5-yl)-phenyl]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-[2-(5-Carboxy-thiophen-2-yl)-phenyl]-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-(4′-methylcarbamoyl-biphenyl-2-yl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-[3′-(2-methyl-cyclopropylmethoxy)-biphenyl-2-yl]-1,3,8-triaza-spiro[4.5]dec-3-en-2-one;

1-(4′-Cyanomethyl-biphenyl-2-yl)-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-(4′-dimethylsulfamoyl-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-(4′-isopropoxycarbonyl-biphenyl-2-yl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-(4′-ethanesulfonyl-4-fluoro-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(4′-Ethanesulfonyl-4-fluoro-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-4-isopropylamino-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-[4′-(methanesulfonylamino-methyl)-biphenyl-2-yl]-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-[5-fluoro-2-(1-methyl-1H-pyrazol-4-yl)-phenyl]-8-(3-isopropoxy-benzyl)-1,3,8-triaza-spiro[4.5]dec-3-en-2-one;

4-Cyclohexylamino-1-(5-fluoro-2-pyridin-3-yl-phenyl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-[2-(2-methanesulfonyl-acetylamino)-phenyl]-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-[4-methanesulfonyl-benzoylamino)-phenyl]-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(4′-Ethanesulfonyl-4-fluoro-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-4-(tetrahydro-pyran-4-ylamino)-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-(4-fluoro-4′-methylsulfamoyl-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclopropylamino-1-(4′-ethanesulfonyl-4-fluoro-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-[5-fluoro-2-(1-methanesulfonyl-1H-pyrazol-4-yl)-phenyl]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

Ethanesulfonic acid {2′-[4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3,8-triaza-spiro[4.5]dec-3-en-1-yl]-4′-fluoro-biphenyl-4-yl}-amide;

4-Cyclohexylamino-1-[4-fluoro-4′-(pyrrolidine-1-sulfonyl)-biphenyl-2-yl]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-(4′-Dimethylsulfamoyl-4-fluoro-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-4-isopropylamino-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-(5-fluoro-3′-trifluoromethanesulfonylamino-biphenyl-3-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-[3′-(Butane-2-sulfonylamino)-5-fluoro-biphenyl-3-yl]-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

2′-[4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3,8-triaza-spiro[4.5]dec-3-en-1-yl]-4′-fluoro-biphenyl-3-sulfonic acid methylamide;

4-Cyclohexylamino-1-[4′-(1,1-dioxo-1,6-isothiazolidin-2-yl)-4-fluoro-biphenyl-2-yl]-8-(3-isopropoxy-benzyl)-1,3,8-triaza-spiro[4.5]dec-3-en-2-one;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-[3-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-1-[3-(3,5-dimethyl-isoxazol-4-yl)-5-fluoro-phenyl]-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-[3-(5-Carboxy-thiophen-2-yl)-5-fluorophenyl]-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclopentylamino-1-(4-fluoro-4′-methanesulfonyl-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-sec-Butylamino-1-(4-fluoro-4′-methanesulfonyl-biphenyl-2-yl)-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

1-[2-(4-Acetylamino-piperidin-1-yl)-5-fluorophenyl]-4-cyclohexylamino-8-(3-isopropoxy-benzyl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-cyclopropylmethyl-1-(4′-dimethylsulfamoyl-4-fluoro-biphenyl-2-yl)-2-oxo-1,3-diaza-8-azonia-spiro[4.5]dec-3-ene;

4-Cyclohexylamino-8-(3-isopropoxy-benzyl)-1-(2-pyrazol-1-yl-phenyl)-1,3,8-triaza-spiro[4.5]dec-3-en-2-one;

N-{3′-fluoro-5′-[8-isobutyl-4-(isopropylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]biphenyl-3-yl}-β-alaninamide[15-45]

2′-[4-(cyclohexylamino)-8-(cyclopropylmethyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]-4′-fluoro-N,N-dimethylbiphenyl-4-sulfonamide[15-46]

4-(cyclohexylamino)-8-(3-isopropoxybenzyl)-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one; and

N-(1-{2-[4-(cyclohexylamino)-8-(3-isopropoxybenzyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]-4-fluorophenyl}piperidin-4-yl)acetamide;

and pharmaceutically acceptable salts thereof.

Assignments (6)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 25, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023837/0668 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2007
From: BARROW, JAMES C.; COBURN, CRAIG A.; EGBERTSON, MELISSA B.; MCGAUGHEY, GEORGIA B.; MCWHERTER, MELODY A.; NEILSON, LOU ANNE; RITTLE, KENNETH E.; SELNICK, HAROLD G.; STAUFFER, SHAUN R.; YANG, ZHI-QIAN
To: MERCK & CO., INC.
Reel/Frame 019670/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2007
From: YANG, WENJIN; LU, WANLI; FAHR, BRUCE
To: SUNESIS PHARMACUTICALS, INC.
Reel/Frame 019670/0167 →